Fondation Ophtalmologique A. de Rotchschild
Paris, 75019, France
NCT Number: NCT02434588
During cataract surgery, it is necessary to dilate the iris in order to remove the crystalline lens and position the implant. The diameter of the optical implant being 6 mm, in case of capsulorhexis crystalline access 5.5 mm, the expansion should be at least 6 mm.
At pre-operative consultation, the iris is always dilated by instillation of eye drops and measured at the slitlamp. For patients with an inadequate dilation, the intervention requires the use of a mechanical dilatation device.
This study aims to assess the value of an alternative dilatation ring to Malyugin ring, which can be inserted and removed through an incision of less than 2 mm in diameter, due to its size smaller than that of the Malyugin ring.
Our hypothesis is that this Bhattacharjee ring ensures sufficient and stable iris dilation during surgery, enabling implant placement in good conditions.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, 75019, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Insertion of a Bhattacharjee ring to stabilise the pupil during cataract surgery
Time frame: Immediately after ring insertion
Time frame: Immediately before ring insertion
Time frame: Just before ring removal
Time frame: Immediatly after ring removal
Time frame: Immediatly after ring insertion
Time frame: Just before ring insertion
Fondation Ophtalmologique Adolphe de Rothschild
Network
Evaluation of an Iris Dilatation Ring in Cataract Surgery
Acronym: ADICC-ID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03206983
Cataract, Eye Diseases
View Trial DetailsNCT06783686
Eye Diseases, Miosis
Chandler, Arizona, United States
View Trial DetailsNCT05391555
Eye Diseases, Miosis
San Francisco, California, United States
View Trial DetailsNCT06045299
Eye Diseases, Miosis
Wenzhou, Zhejiang, China
View Trial Details